Abstract
Background: Naturally occurring bioactive compounds have a plethora of biological effects.
Objective: In this study, we examined a pharmacological screening of natural products on the human umbilical artery (HUA).
Methods: HUA preparations were used to follow contractions by KCl (60 mM) and tested at different concentrations (1-5000 μg/mL and μM) of the Lippia alba (EOLa) and Lippia origanoides (EOLo) essential oils, terpenes (citral, limonene perilic alcohol) and phenylpropanoids (eugenol, methyl eugenol).
Results: The reduction corresponded to approximately 100%, except for limonene (80 ± 1.2%). When evaluating the concentration of the natural product that promotes 50% relaxation of the HUA contracted by KCL, EC50 values were: 424.3 μg/mL (EOLa); 468.7 ± 6.7 μg/mL (EOLo); 264.2 ± 8.2 μM (citral); 677.8 ± 5.4 μM (limonene); 186.3 ± 6.4 μM (peryl alcohol); 986.4 ± 7.9 μM (eugenol); and 279.1 ± 4.4 μM (methyl-eugenol). Perillyl alcohol had a lower EC50 (consequently it has a higher pharmacological potency).
Conclusion: The plant extracts have a promising vasorelaxing effect in HUAs, paving the way for future investigations: as applications in diseases related to these vessels, such as preeclampsia.
Keywords: Vasorrelaxant, smooth muscle, natural products, human umbilical artery, terpenes, phenylpropanoids, preeclampsia.
[http://dx.doi.org/10.4236/pp.2013.43A003]
[http://dx.doi.org/10.1016/S0140-6736(10)60279-6] [PMID: 20598363]
[http://dx.doi.org/10.4103/jfmpc.jfmpc_132_17] [PMID: 29564260]
[http://dx.doi.org/10.1016/j.ajog.2015.04.013] [PMID: 26004324]
[http://dx.doi.org/10.1016/j.fct.2007.09.106] [PMID: 17996351]
[http://dx.doi.org/10.1590/S0100-40422004000100011]
[http://dx.doi.org/10.1016/j.biopha.2018.09.073] [PMID: 30253371]
[http://dx.doi.org/10.1016/j.cbi.2018.11.006] [PMID: 30447181]
[http://dx.doi.org/10.1016/j.btre.2017.12.002] [PMID: 29619330]
[http://dx.doi.org/10.3390/molecules23061430] [PMID: 29899230]
[http://dx.doi.org/10.1016/j.lfs.2003.09.063] [PMID: 14998717]
[http://dx.doi.org/10.1111/j.1472-8206.2009.00768.x] [PMID: 19682086]
[http://dx.doi.org/10.1016/j.cellbi.2008.01.234]
[http://dx.doi.org/10.3389/fbioe.2020.00117] [PMID: 32211387]
[http://dx.doi.org/10.3390/app10030938]
[http://dx.doi.org/10.1590/1414-431x20154710] [PMID: 26132093]
[http://dx.doi.org/10.1590/1414-431x20176351] [PMID: 29069226]
[http://dx.doi.org/10.1152/ajpheart.00938.2002] [PMID: 12969885]
[http://dx.doi.org/10.1254/jjp.79.327] [PMID: 10230861]
[http://dx.doi.org/10.1211/002235702694] [PMID: 12724042]
[http://dx.doi.org/10.1111/bph.13156] [PMID: 25832173]
[http://dx.doi.org/10.1016/S1537-1891(02)00311-7] [PMID: 12646411]
[http://dx.doi.org/10.1097/FJC.0000000000000131] [PMID: 24921632]
[http://dx.doi.org/10.1016/S1071-5576(03)00149-7] [PMID: 14662162]
[http://dx.doi.org/10.4236/health.2010.24049]
[http://dx.doi.org/10.1055/s-2000-8594] [PMID: 10909258]
[http://dx.doi.org/10.1139/y02-117] [PMID: 12430985]
[http://dx.doi.org/10.3390/molecules25112681] [PMID: 32527034]
[http://dx.doi.org/10.1016/j.foodchem.2013.11.018] [PMID: 24423518]
[http://dx.doi.org/10.1007/BF03179062] [PMID: 19886390]
[http://dx.doi.org/10.1111/jog.12624] [PMID: 25511326]
[http://dx.doi.org/10.1016/j.pharmthera.2006.08.009] [PMID: 17069890]
[http://dx.doi.org/10.1111/j.1399-6576.2006.01210.x] [PMID: 17181535]
[http://dx.doi.org/10.1111/jam.13398] [PMID: 28055127]
[http://dx.doi.org/10.1016/j.etap.2018.03.016] [PMID: 29605588]
[PMID: 32439587]
[http://dx.doi.org/10.1016/0278-6915(92)90003-4] [PMID: 1628861]
[http://dx.doi.org/10.1016/j.ijantimicag.2017.08.025] [PMID: 28843818]
[PMID: 18072821]
[http://dx.doi.org/10.4274/tjps.62207]